Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 7, 2014, Pages

  Chen, Lihong ^a   Zheng, Lin ^a   He, Wubing ^a   Qiu, Minglian ^a   Gao, Lingyun ^a   Liu, Jingfeng ^a   Huang, Aimin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Dendritic cells; Immune tolerance; Interleukin 10; Liver transplantation; Transforming growth factor 1

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CELL THERAPY AGENT; INTERLEUKIN 10; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT REJECTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL THERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; LIVER GRAFT; LIVER GRAFT REJECTION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT MODEL; SURVIVAL TIME; TRANSPLANTATION TOLERANCE;

DENDRITIC CELLS; IMMUNE TOLERANCE; INTERLEUKIN-10; LIVER TRANSPLANTATION; TRANSFORMING GROWTH FACTOR-Β1;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; BILIRUBIN; BIOLOGICAL MARKERS; CELLS, CULTURED; DENDRITIC CELLS; GENETIC THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; ISOANTIGENS; LIVER; LIVER TRANSPLANTATION; MALE; MODELS, ANIMAL; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION TOLERANCE;

EID: 84900554690     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00283.2013     Document Type: Article

References (26)

1. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, ten Brinke A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-a comparative study of human clinical-applicable DC. Clin Immunol 142: 332-342, 2012.
2. Boks MA, Zwaginga JJ, van Ham SM, ten Brinke A. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells. Scand J Immunol 72: 158-168, 2010.
3. Cai Z, Zhang W, Li M, Yue Y, Yang F, Yu L, Cao X, Wang J. TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4()Foxp3() regulatory T cells. Cell Mol Immunol 7: 35-43, 2010.
4. Chen L, Qiu M, He W, Huang A, Liu J. Functional study of immature dendritic cells co-transfected with IL-10 and TGF-beta 1 genes in vitro. Mol Biol Rep 39: 6633-6639, 2012.
5. Cools N, Van Tendeloo VF, Smits EL, Lenjou M, Nijs G, Van Bockstaele DR, Berneman ZN, Ponsaerts P. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 doublepositive CD4 regulatory T cells. J Cell Mol Med 12: 690-700, 2008.
6. Dandel M, Lehmkuhl HB, Knosalla C, Hetzer R. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation. Transplant Immunol 23: 93-103, 2010.
7. de Kort H, Crul C, van der Wal AM, Schlagwein N, Stax AM, Bruijn JA, van Kooten C, de Heer E. Accelerated antibody-mediated graft loss of rodent pancreatic islets after pretreatment with dexamethasone-treated immature donor dendritic cells. Transplantation 94: 903-910, 2012.
8. Felker P, Sere K, Lin Q, Becker C, Hristov M, Hieronymus T, Zenke M. TGF-beta1 accelerates dendritic cell differentiation from common dendritic cell progenitors and directs subset specification toward conventional dendritic cells. J Immunol 185: 5326-5335, 2010.
9. Girard-Madoux MJ, Kel JM, Reizis B, Clausen BE. IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J Allergy Clin Immunol 129: 143-150 e141-110, 2012.
10. Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, Hauben E, Roncarolo MG. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/ HLA-G pathway. Blood 116: 935-944, 2010.
11. Griffiths KL, O'Neill HC. Dendritic cells as immune regulators: the mouse model. J Cell Mol Med 12: 1909-1914, 2008.
12. Heise N, Shumilina E, Nurbaeva MK, Schmid E, Szteyn K, Yang W, Xuan NT, Wang K, Zemtsova IM, Duszenko M, Lang F. Effect of dexamethasone on Na /Ca2 exchanger in dendritic cells. Am J Physiol Cell Physiol 300: C1306-C1313, 2011.
13. Horoldt BS, Burattin M, Gunson BK, Bramhall SR, Nightingale P, Hubscher SG, Neuberger JM. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver Transplant 12: 1144-1151, 2006.
14. Li N, Cai CJ, Wu YR, Lu MQ. A technique of recipient portal venoplasty and cuff insertion for portal revascularization in orthotopic rat liver transplantation. J Surg Res 176: 317-320, 2012.
15. Macomber CW, Shah SA. A technique of recipient portal venoplasty and cuff insertion for portal revascularization in orthotopic rat liver transplantation. J Surg Res 179: 45-46, 2013.
16. Mantel PY, Schmidt-Weber CB. Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 677: 303-338, 2011.
17. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol 24: 36-43, 2003.
18. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, Sensebe L, Zhang Y, Gorin NC, Thierry D, Fouillard L. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expression 13: 217-226, 2007.
19. Peng Y, Gong JP, Yan LN, Li SB, Li XH. Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobil Pancreatic Dis Int 3: 33-37, 2004.
20. Placek K, Coffre M, Maiella S, Bianchi E, Rogge L. Genetic and epigenetic networks controlling T helper 1 cell differentiation. Immunology 127: 155-162, 2009.
21. Reichardt W, Durr C, von Elverfeldt D, Juttner E, Gerlach UV, Yamada M, Smith B, Negrin RS, Zeiser R. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J Immunol 181: 4770-4779, 2008.
22. Spender LC, O'Brien DI, Simpson D, Dutt D, Gregory CD, Allday MJ, Clark LJ, Inman GJ. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ 16: 593-602, 2009.
23. Thomson AW, Turnquist HR, Zahorchak AF, Raimondi G. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation 87: S86-S90, 2009.
24. van der Aar AM, Sibiryak DS, Bakdash G, van Capel TM, van der Kleij HP, Opstelten DJ, Teunissen MB, Kapsenberg ML, de Jong EC. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol 127: 1532-1540, 2011.
25. Wing K, Fehervari Z, Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol 18: 991-1000, 2006.
26. Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31: 220-227, 2010.